XBIT logo

XBiotech (XBIT)

Profile

Full Name

XBiotech Inc.

Ticker Symbol

XBIT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 15, 2015

Indexes

Not included

Website

http://www.xbiotech.com

Employees

92

Key Details

Price

$3.12(-4.88%)

Market cap

Last Dividend

$2.10

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.26(-55.56% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.12
XBIT price is $3.12

30-Day Relative Volume

0.77
XBIT 30-day relative volume is 0.77

Price Performance

Price Most recent change

-4.88%
XBIT price was down -4.88% on Apr 14, 2025

Price YTD change

-21.01%
XBIT price is down -21.01% since January 1st

Price 1-year change

-66.84%
XBIT price is down -66.84% year-on-year

Price 3-year change

-62.55%
XBIT price is down -62.55% over the past 3 years

Price Range

Price All-time high

$32.50
XBIT price is currently -90.40% below its historical high of $32.50

Price 3-year low

$2.65
XBIT price is currently +17.74% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$95.12M
XBIT market capitalization is $95.12 million

Market cap 3-year change

-62.49%
XBIT market capitalization is down -62.49% over the past 3 years

Market cap All-time high

$1.06B
XBIT market capitalization is currently -91.00% below its historical high of $1.06 billion

Market cap sector rank

48.11%
XBIT market capitalization is higher than 48.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.12%
XBIT shares outstanding is up +0.12% year-on-year

Shares Outstanding 3-Year Change

+0.16%
XBIT shares outstanding is up +0.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.45
XBIT beta is 1.45

200-day SMA

$5.52
XBIT price is currently -43.49% below its 200-day simple moving average

50-day SMA

$3.21
XBIT price is currently -2.94% below its 50-day simple moving average

RSI

48.06
XBIT 14-day relative strength index is 48.06

Volume

0.77
XBIT 30-day relative volume is 0.77

ATR

$0.32
XBIT average true range is $0.32

10-day Historical Volatility

137.62%
XBIT 10-day historical volatility is 137.62%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.10
XBIT last dividend was $2.10 per share, with an ex-dividend date of July 15, 2021

Next Dividend

-
XBIT next dividend has not yet been announced

Dividend per share

Dividend per share

-
XBIT annual dividend per share value is unknown

Dividend per share Sector Rank

-
XBIT annual dividend per share is unknown

Dividend per share 1-Year Change

-
XBIT annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
XBIT annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
XBIT annual dividend yield value is unknown

Dividend yield Sector Rank

-
XBIT annual dividend yield is unknown

Other

Payout ratio

-
XBIT annual payout ratio value is unknown

Dividends paid

-
XBIT annual dividends paid value is unknown

Free cash flow

-$32.27M
XBIT annual free cash flow is -$32.27 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
XBIT annual revenue value is unknown

Revenue Analysts estimate

-
XBIT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
XBIT annual revenue 1-year change is unknown

Revenue Sector rank

-
XBIT annual revenue is unknown

EPS

EPS

-$1.26
XBIT annual earnings per share is -$1.26

EPS Analysts estimate

-
XBIT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-55.56%
XBIT annual earnings per share is down -55.56% year-on-year

EPS Sector rank

50.87%
XBIT annual earnings per share is higher than 50.87% of companies in Healthcare sector

Profit

Gross profit

-
XBIT annual gross profit value is unknown

Gross margin

-
XBIT annual gross profit margin value is unknown

Operating profit

-$42.47M
XBIT annual operating income is -$42.47 million

Operating margin

-
XBIT annual operating profit margin value is unknown

Net income

-$38.53M
XBIT annual net profit is -$38.53 million

Net margin

-
XBIT annual net profit margin value is unknown

Expenses

Total expenses

$42.47M
XBIT annual total expenses is $42.47 million

Operating expenses

$42.47M
XBIT annual total operating expenses is $42.47 million

Cost of goods sold

-
XBIT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.71M
XBIT annual SGA is $4.71 million

Depreciation and amortization

$1.75M
XBIT annual depreciation & amortization is $1.75 million

Interest expense

$807.00K
XBIT annual interest expense is $807.00 thousand

Income tax

-$32.00K
XBIT annual income tax is -$32.00 thousand

EBIT & EBITDA

EBIT

-$37.76M
XBIT annual earnings before interest & taxes is -$37.76 million

EBITDA

-$36.01M
XBIT annual EBITDA is -$36.01 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$199.09M
XBIT annual total assets is $199.09 million

Non current assets

$24.53M
XBIT annual long term assets is $24.53 million

Current assets

$174.57M
XBIT annual total current assets is $174.57 million

Cash and cash equivalents

$172.68M
XBIT annual cash & cash equivalents is $172.68 million

Accounts receivable

-
XBIT annual accounts receivable value is unknown

Inventory

-
XBIT annual inventory value is unknown

Liabilities

Total liabilities

$16.82M
XBIT annual total liabilities is $16.82 million

Long term liabilities

$1.72M
XBIT annual total long term liabilities is $1.72 million

Current liabilities

$15.11M
XBIT annual total current liabilities is $15.11 million

Accounts payable

$2.22M
XBIT annual accounts payable is $2.22 million

Debt

Total debt

$10.25M
XBIT annual total debt is $10.25 million

Total debt 1-year change

+100%
XBIT annual total debt is up +100% year-on-year

Long term debt

-
XBIT annual long term debt value is unknown

Short term debt

$10.25M
XBIT annual short term debt is $10.25 million

Equity & Capital

Shareholders equity

$182.27M
XBIT annual stockholders equity is $182.27 million

Book value

$182.27M
XBIT annual book value is $182.27 million

Retained earnings

-$90.84M
XBIT annual retained earnings is -$90.84 million

Working capital

$159.46M
XBIT annual working capital is $159.46 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$30.96M
XBIT annual cash flow from operations is -$30.96 million

Cash from operations 1-year change

-65.36%
XBIT annual cash flow from operations is down -65.36% year-on-year

Cash from investing

-$1.30M
XBIT annual cash flow from investing activities is -$1.30 million

Cash from investing 1-year change

-102.12%
XBIT annual cash flow from investing activities is down -102.12% year-on-year

Cash from financing

$10.45M
XBIT annual cash flow from financing activities is $10.45 million

Cash from financing 1-year change

+116211.11%
XBIT annual cash flow from financing activities is up +116211.11% year-on-year

CAPEX

CAPEX

-
XBIT annual capital expenditures value is unknown

CAPEX 1-year change

-
XBIT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$32.27M
XBIT annual free cash flow is -$32.27 million

Free cash flow 1-year change

-69.05%
XBIT annual free cash flow is down -69.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
XBIT annual gross profit margin value is unknown

Operating margin

-
XBIT annual operating profit margin value is unknown

Net margin

-
XBIT annual net profit margin value is unknown

ROA & ROE

ROA

-19.35%
XBIT annual return on assets is -19.35%

ROE

-21.14%
XBIT annual return on equity is -21.14%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XBIT price to earnings ratio value is unknown

PE ratio Sector rank

-
XBIT price to earnings ratio is unknown

PB Ratio

PB ratio

0.52
XBIT price to book ratio is 0.52

PB ratio Sector rank

30.7%
XBIT price to book ratio is higher than 30.7% of companies in Healthcare sector

PS Ratio

PS ratio

-
XBIT price to sales ratio value is unknown

PS ratio Sector rank

-
XBIT price to sales ratio is unknown

Enterprise value

Enterprise value

-$67.31M
XBIT enterprise value is -$67.31 million

Enterprise value Sector rank

1.16%
XBIT enterprise value is higher than 1.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

1.72
XBIT EV/EBITDA is 1.72

EV/EBITDA Sector rank

75.74%
XBIT EV/EBITDA is higher than 75.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.56
XBIT annual current ratio is 11.56

Quick ratio

-
XBIT annual quick ratio value is unknown

Leverage

Debt to equity

0.06
XBIT annual debt to equity ratio is 0.06

Interest coverage ratio

-46.79
XBIT annual interest coverage ratio is -46.79

Risk & Stability

Piotroski F-Score

-
XBIT piotroski f-score value is unknown

Altman Z-Score

-
XBIT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 7, 20 Piper Sandler
Overweight
Dec 11, 19 PiperJaffray
Overweight
Dec 11, 19 Piper Sandler
Overweight
Jun 14, 19 Piper Sandler
Overweight
Jun 14, 19 Piper Jaffray
Overweight

Institutional Ownership

Similar stocks

eXoZymes (EXOZ)
PROK logo
ProKidney (PROK)
RPID logo
Rapid Micro Biosystems (RPID)
MGRM logo
Monogram Orthopaedics (MGRM)
KYTX logo
Kyverna Therapeutics (KYTX)
TLSA logo
Tiziana Life Sciences Ltd (TLSA)
ALEC logo
Alector (ALEC)
ORMP logo
Oramed Pharmaceuticals (ORMP)
Anteris Technologies Global (AVR)
  • What is the ticker symbol for XBiotech?
  • Does XBiotech pay dividends?
  • What sector is XBiotech in?
  • What industry is XBiotech in?
  • What country is XBiotech based in?
  • When did XBiotech go public?
  • Is XBiotech in the S&P 500?
  • Is XBiotech in the NASDAQ 100?
  • Is XBiotech in the Dow Jones?
  • When was XBiotech's last earnings report?
  • When does XBiotech report earnings?
  • Should I buy XBiotech stock now?

What is the ticker symbol for XBiotech?

The ticker symbol for XBiotech is NASDAQ:XBIT

Does XBiotech pay dividends?

No, XBiotech does not pay dividends

What sector is XBiotech in?

XBiotech is in the Healthcare sector

What industry is XBiotech in?

XBiotech is in the Biotechnology industry

What country is XBiotech based in?

XBiotech is headquartered in United States

When did XBiotech go public?

XBiotech's initial public offering (IPO) was on April 15, 2015

Is XBiotech in the S&P 500?

No, XBiotech is not included in the S&P 500 index

Is XBiotech in the NASDAQ 100?

No, XBiotech is not included in the NASDAQ 100 index

Is XBiotech in the Dow Jones?

No, XBiotech is not included in the Dow Jones index

When was XBiotech's last earnings report?

XBiotech's most recent earnings report was on Nov 13, 2024

When does XBiotech report earnings?

The next expected earnings date for XBiotech is May 9, 2025

Should I buy XBiotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page